ABOUT US.
PhotoSonX (Canada) Inc, was created to bring the well-tested breakthrough SPDT technology to Europe and the Americas (Western Hemisphere exclusive licensee). This technology is owned by Science Group Pty Limited, of Australia, and has almost completed the regulatory approval process in China,
PhotoSonX is led in Canada by Tony Humble, a seasoned entrepreneur and also current Chairman of TeloRegen Inc., a Michigan-based biotech company focused on telomere regeneration.
PhotoSonX (Canada) Inc.'s Mission is to enable Sono and Photodynamic therapy technology to achieve full regulatory approval in North America and Europe and be readily available as a treatment option to the global community.
We believe the effectiveness, safety, reasonable price, complete absence of toxicity and wide range of medical applications will lead to the successful treatment of many problematic diseases and usher in a Golden Age of Medicine.
The SPDT technique has been used to great effect in treating many Stage 4 cancer patients at Science Group’s supported prominent cancer clinics in Guangzhou, China, and results are available for professional review, including peer-reviewed articles.
This website contains a wealth of information on the 10+ year history and results of these game-changing therapies in Guangzhou.
Please help us to spread the word, and to ensure that the information here gets to the right people who can promote the required testing.
Thank you for your interest and support.
The PhotoSonX and Science Group Teams.